Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
Novoplansky, Ofra, Shnerb, Avital B., Marripati, Divyasree, Jagadeeshan, Sankar, Abu Shareb, Raghda, Conde‐López, Cristina, Zorea, Jonathan, Prasad, Manu, Ben Lulu, Talal, Yegodayev, Ksenia M., Benafsha, Chen, Li, Yushi, Kong, Dexin, Kuo, Fengshen, Morris, Luc G. T., Kurth, Ina, Hess, Jochen, Elkabets, Moshe
Published in Molecular oncology (01.12.2023)
Published in Molecular oncology (01.12.2023)
Get full text
Journal Article
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer
Prasad, Manu, Zorea, Jonathan, Jagadeeshan, Sankar, Shnerb, Avital B, Mathukkada, Sooraj, Bouaoud, Jebrane, Michon, Lucas, Novoplansky, Ofra, Badarni, Mai, Cohen, Limor, Yegodayev, Ksenia M, Tzadok, Sapir, Rotblat, Barak, Brezina, Libor, Mock, Andreas, Karabajakian, Andy, Fayette, Jérôme, Cohen, Idan, Cooks, Tomer, Allon, Irit, Dimitstein, Orr, Joshua, Benzion, Kong, Dexin, Voronov, Elena, Scaltriti, Maurizio, Carmi, Yaron, Conde-Lopez, Cristina, Hess, Jochen, Kurth, Ina, Morris, Luc G T, Saintigny, Pierre, Elkabets, Moshe
Published in Journal for immunotherapy of cancer (01.03.2022)
Published in Journal for immunotherapy of cancer (01.03.2022)
Get full text
Journal Article